Submission Details
| 510(k) Number | K102416 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 24, 2010 |
| Decision Date | October 20, 2011 |
| Days to Decision | 422 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K102416 is an FDA 510(k) clearance for the BD GENEOHM VANR ASSAY, a System, Test, Genotypic Detection, Resistant Markers, Enterococcus Species (Class II — Special Controls, product code NIJ), submitted by Bd Diagnostics Science (Sparks, US). The FDA issued a Cleared decision on October 20, 2011, 422 days after receiving the submission on August 24, 2010. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.1640.
| 510(k) Number | K102416 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 24, 2010 |
| Decision Date | October 20, 2011 |
| Days to Decision | 422 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | NIJ — System, Test, Genotypic Detection, Resistant Markers, Enterococcus Species |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.1640 |
| Definition | The In Vitro Device Is Intended To Detect The Presence Of The Vana And Vanb Genes In Isolated Colonies Of Enterococcus Spp. As A Marker For Vancomycin Resistance Using Dna Probe Technology |